FDA Agrees With GAO Recommendations To Give Prosecutions Higher Priority
This article was originally published in The Tan Sheet
Executive Summary
FDA's plans to increase prosecutions of noncompliant food and drug industry officials, as recommended by an internal committee, should include the dietary supplement market, stakeholders say